HEADER TRANSFERASE/TRANSFERASE INHIBITOR 03-APR-17 5VDK TITLE CRYSTAL STRUCTURE OF HUMAN WEE2 KINASE DOMAIN IN COMPLEX WITH MK1775 COMPND MOL_ID: 1; COMPND 2 MOLECULE: WEE1-LIKE PROTEIN KINASE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 202-492; COMPND 5 SYNONYM: WEE1-LIKE PROTEIN KINASE 1B,WEE1B KINASE; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WEE2, WEE1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-RIPL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS KINASE DOMAIN, CELL CYCLE, WEE2, TRANSFERASE, INHIBITOR, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.-Y.ZHU,E.SCHONBRUNN REVDAT 4 04-OCT-23 5VDK 1 REMARK REVDAT 3 11-DEC-19 5VDK 1 REMARK REVDAT 2 11-OCT-17 5VDK 1 JRNL REVDAT 1 23-AUG-17 5VDK 0 JRNL AUTH J.Y.ZHU,R.A.CUELLAR,N.BERNDT,H.E.LEE,S.H.OLESEN,M.P.MARTIN, JRNL AUTH 2 J.T.JENSEN,G.I.GEORG,E.SCHONBRUNN JRNL TITL STRUCTURAL BASIS OF WEE KINASES FUNCTIONALITY AND JRNL TITL 2 INACTIVATION BY DIVERSE SMALL MOLECULE INHIBITORS. JRNL REF J. MED. CHEM. V. 60 7863 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28792760 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00996 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.79 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 8421 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 422 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 18.7940 - 3.8869 1.00 2663 141 0.2048 0.2500 REMARK 3 2 3.8869 - 3.0896 1.00 2669 140 0.2369 0.3034 REMARK 3 3 3.0896 - 2.7003 1.00 2667 141 0.2688 0.3579 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.480 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.370 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.12 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2143 REMARK 3 ANGLE : 0.704 2901 REMARK 3 CHIRALITY : 0.048 309 REMARK 3 PLANARITY : 0.004 369 REMARK 3 DIHEDRAL : 7.776 1269 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 204 THROUGH 243 ) REMARK 3 ORIGIN FOR THE GROUP (A): -4.9923 -34.7134 -14.1907 REMARK 3 T TENSOR REMARK 3 T11: 0.4188 T22: 0.3420 REMARK 3 T33: 0.2692 T12: 0.0097 REMARK 3 T13: 0.1093 T23: 0.0223 REMARK 3 L TENSOR REMARK 3 L11: 3.5574 L22: 5.4725 REMARK 3 L33: 5.0452 L12: 0.7230 REMARK 3 L13: 1.1295 L23: 0.7182 REMARK 3 S TENSOR REMARK 3 S11: 0.4138 S12: 0.2626 S13: -0.0531 REMARK 3 S21: 0.0853 S22: -0.3593 S23: 0.2399 REMARK 3 S31: 0.3875 S32: -0.0379 S33: -0.0047 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 244 THROUGH 265 ) REMARK 3 ORIGIN FOR THE GROUP (A): 3.2253 -22.6406 -1.4271 REMARK 3 T TENSOR REMARK 3 T11: 0.4503 T22: 0.3726 REMARK 3 T33: 0.5737 T12: -0.0378 REMARK 3 T13: 0.0165 T23: -0.0587 REMARK 3 L TENSOR REMARK 3 L11: 4.8763 L22: 3.8757 REMARK 3 L33: 7.9332 L12: -2.6620 REMARK 3 L13: -0.7857 L23: 1.8015 REMARK 3 S TENSOR REMARK 3 S11: -0.0966 S12: -0.3220 S13: 1.0473 REMARK 3 S21: 0.1236 S22: 0.6053 S23: -1.1851 REMARK 3 S31: -0.7245 S32: 0.9381 S33: 0.1058 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 266 THROUGH 486 ) REMARK 3 ORIGIN FOR THE GROUP (A): -14.4781 -12.3066 -4.4716 REMARK 3 T TENSOR REMARK 3 T11: 0.4246 T22: 0.4634 REMARK 3 T33: 0.5305 T12: 0.1767 REMARK 3 T13: -0.0182 T23: -0.0306 REMARK 3 L TENSOR REMARK 3 L11: 2.4581 L22: 4.8198 REMARK 3 L33: 3.3362 L12: -1.4605 REMARK 3 L13: -0.3381 L23: 0.8026 REMARK 3 S TENSOR REMARK 3 S11: -0.0260 S12: -0.0829 S13: 0.6377 REMARK 3 S21: 0.0320 S22: -0.0794 S23: 0.3422 REMARK 3 S31: -0.6448 S32: -0.6760 S33: -0.0484 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VDK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-APR-17. REMARK 100 THE DEPOSITION ID IS D_1000227257. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8422 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 18.794 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.374 REMARK 200 R MERGE (I) : 0.09700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.44 REMARK 200 R MERGE FOR SHELL (I) : 0.57000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1X8B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14 MG/ML WEE2, 25 MM TRIS PH 8.0, 1 MM REMARK 280 DTT, 0.2 M AMMONIUM PHOSPHATE MONOBASIC, 1.5 MM MK1775, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.69333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.34667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 196 REMARK 465 PRO A 197 REMARK 465 GLU A 198 REMARK 465 PHE A 199 REMARK 465 GLY A 200 REMARK 465 SER A 201 REMARK 465 THR A 202 REMARK 465 ASN A 203 REMARK 465 MET A 351 REMARK 465 GLN A 352 REMARK 465 SER A 353 REMARK 465 GLU A 354 REMARK 465 SER A 355 REMARK 465 SER A 356 REMARK 465 GLY A 357 REMARK 465 VAL A 358 REMARK 465 ILE A 359 REMARK 465 GLU A 360 REMARK 465 GLU A 361 REMARK 465 VAL A 362 REMARK 465 GLU A 363 REMARK 465 ASN A 364 REMARK 465 GLU A 365 REMARK 465 ALA A 366 REMARK 465 ASP A 367 REMARK 465 TRP A 368 REMARK 465 PHE A 369 REMARK 465 LEU A 370 REMARK 465 SER A 371 REMARK 465 ALA A 372 REMARK 465 ASN A 373 REMARK 465 ARG A 487 REMARK 465 PRO A 488 REMARK 465 SER A 489 REMARK 465 LEU A 490 REMARK 465 GLY A 491 REMARK 465 LYS A 492 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 205 -165.72 -104.47 REMARK 500 THR A 248 -130.70 -151.73 REMARK 500 GLU A 249 -148.90 -132.94 REMARK 500 SER A 251 -162.43 -71.71 REMARK 500 ASN A 252 -82.48 61.00 REMARK 500 GLU A 253 46.25 -78.26 REMARK 500 ASP A 339 39.21 -157.87 REMARK 500 HIS A 349 73.70 51.94 REMARK 500 ASP A 380 97.22 59.49 REMARK 500 LYS A 445 30.09 -94.23 REMARK 500 PRO A 452 77.38 -62.94 REMARK 500 GLN A 453 143.45 -177.97 REMARK 500 ASP A 470 108.64 50.12 REMARK 500 ALA A 471 -66.57 -166.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues 8X7 A 501 and PO4 A REMARK 800 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5VC3 RELATED DB: PDB REMARK 900 RELATED ID: 5VC4 RELATED DB: PDB REMARK 900 RELATED ID: 5VC5 RELATED DB: PDB REMARK 900 RELATED ID: 5VD2 RELATED DB: PDB REMARK 900 RELATED ID: 5VC6 RELATED DB: PDB REMARK 900 RELATED ID: 5VD9 RELATED DB: PDB REMARK 900 RELATED ID: 5VD8 RELATED DB: PDB REMARK 900 RELATED ID: 5VD7 RELATED DB: PDB REMARK 900 RELATED ID: 5VD5 RELATED DB: PDB REMARK 900 RELATED ID: 5VD4 RELATED DB: PDB REMARK 900 RELATED ID: 5VDA RELATED DB: PDB DBREF 5VDK A 202 492 UNP P0C1S8 WEE2_HUMAN 202 492 SEQADV 5VDK GLY A 196 UNP P0C1S8 EXPRESSION TAG SEQADV 5VDK PRO A 197 UNP P0C1S8 EXPRESSION TAG SEQADV 5VDK GLU A 198 UNP P0C1S8 EXPRESSION TAG SEQADV 5VDK PHE A 199 UNP P0C1S8 EXPRESSION TAG SEQADV 5VDK GLY A 200 UNP P0C1S8 EXPRESSION TAG SEQADV 5VDK SER A 201 UNP P0C1S8 EXPRESSION TAG SEQRES 1 A 297 GLY PRO GLU PHE GLY SER THR ASN MET ALA SER ARG TYR SEQRES 2 A 297 GLU LYS GLU PHE LEU GLU VAL GLU LYS ILE GLY VAL GLY SEQRES 3 A 297 GLU PHE GLY THR VAL TYR LYS CYS ILE LYS ARG LEU ASP SEQRES 4 A 297 GLY CYS VAL TYR ALA ILE LYS ARG SER MET LYS THR PHE SEQRES 5 A 297 THR GLU LEU SER ASN GLU ASN SER ALA LEU HIS GLU VAL SEQRES 6 A 297 TYR ALA HIS ALA VAL LEU GLY HIS HIS PRO HIS VAL VAL SEQRES 7 A 297 ARG TYR TYR SER SER TRP ALA GLU ASP ASP HIS MET ILE SEQRES 8 A 297 ILE GLN ASN GLU TYR CYS ASN GLY GLY SER LEU GLN ALA SEQRES 9 A 297 ALA ILE SER GLU ASN THR LYS SER GLY ASN HIS PHE GLU SEQRES 10 A 297 GLU PRO LYS LEU LYS ASP ILE LEU LEU GLN ILE SER LEU SEQRES 11 A 297 GLY LEU ASN TYR ILE HIS ASN SER SER MET VAL HIS LEU SEQRES 12 A 297 ASP ILE LYS PRO SER ASN ILE PHE ILE CYS HIS LYS MET SEQRES 13 A 297 GLN SER GLU SER SER GLY VAL ILE GLU GLU VAL GLU ASN SEQRES 14 A 297 GLU ALA ASP TRP PHE LEU SER ALA ASN VAL MET TYR LYS SEQRES 15 A 297 ILE GLY ASP LEU GLY HIS ALA THR SER ILE ASN LYS PRO SEQRES 16 A 297 LYS VAL GLU GLU GLY ASP SER ARG PHE LEU ALA ASN GLU SEQRES 17 A 297 ILE LEU GLN GLU ASP TYR ARG HIS LEU PRO LYS ALA ASP SEQRES 18 A 297 ILE PHE ALA LEU GLY LEU THR ILE ALA VAL ALA ALA GLY SEQRES 19 A 297 ALA GLU SER LEU PRO THR ASN GLY ALA ALA TRP HIS HIS SEQRES 20 A 297 ILE ARG LYS GLY ASN PHE PRO ASP VAL PRO GLN GLU LEU SEQRES 21 A 297 SER GLU SER PHE SER SER LEU LEU LYS ASN MET ILE GLN SEQRES 22 A 297 PRO ASP ALA GLU GLN ARG PRO SER ALA ALA ALA LEU ALA SEQRES 23 A 297 ARG ASN THR VAL LEU ARG PRO SER LEU GLY LYS HET 8X7 A 501 37 HET PO4 A 502 5 HET PO4 A 503 5 HET PO4 A 504 5 HETNAM 8X7 1-[6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-2-YL]-6-{[4-(4- HETNAM 2 8X7 METHYLPIPERAZIN-1-YL)PHENYL]AMINO}-2-(PROP-2-EN-1-YL)- HETNAM 3 8X7 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE HETNAM PO4 PHOSPHATE ION FORMUL 2 8X7 C27 H32 N8 O2 FORMUL 3 PO4 3(O4 P 3-) FORMUL 6 HOH *7(H2 O) HELIX 1 AA1 SER A 206 GLU A 211 1 6 HELIX 2 AA2 ASN A 254 LEU A 266 1 13 HELIX 3 AA3 SER A 296 SER A 307 1 12 HELIX 4 AA4 GLU A 312 SER A 333 1 22 HELIX 5 AA5 ASP A 396 LEU A 400 5 5 HELIX 6 AA6 ALA A 401 GLN A 406 1 6 HELIX 7 AA7 LEU A 412 GLY A 429 1 18 HELIX 8 AA8 ASN A 436 ARG A 444 1 9 HELIX 9 AA9 SER A 456 GLN A 468 1 13 HELIX 10 AB1 SER A 476 ARG A 482 1 7 SHEET 1 AA1 5 PHE A 212 GLY A 221 0 SHEET 2 AA1 5 GLY A 224 LYS A 231 -1 O VAL A 226 N GLY A 219 SHEET 3 AA1 5 VAL A 237 SER A 243 -1 O TYR A 238 N CYS A 229 SHEET 4 AA1 5 HIS A 284 GLU A 290 -1 O MET A 285 N SER A 243 SHEET 5 AA1 5 TYR A 275 GLU A 281 -1 N TRP A 279 O ILE A 286 SHEET 1 AA2 2 MET A 335 VAL A 336 0 SHEET 2 AA2 2 THR A 385 SER A 386 -1 O THR A 385 N VAL A 336 SHEET 1 AA3 2 ILE A 345 CYS A 348 0 SHEET 2 AA3 2 MET A 375 ILE A 378 -1 O LYS A 377 N PHE A 346 LINK C21 8X7 A 501 O1 PO4 A 502 1555 1555 1.38 CISPEP 1 PHE A 247 THR A 248 0 -22.04 CISPEP 2 ASP A 470 ALA A 471 0 -0.59 SITE 1 AC1 6 HIS A 263 LEU A 266 GLY A 267 VAL A 272 SITE 2 AC1 6 VAL A 273 TYR A 275 SITE 1 AC2 5 ASP A 339 LYS A 341 HIS A 383 GLY A 395 SITE 2 AC2 5 ASP A 396 SITE 1 AC3 16 VAL A 220 GLY A 221 GLU A 222 LYS A 241 SITE 2 AC3 16 GLU A 259 HIS A 263 VAL A 273 ILE A 287 SITE 3 AC3 16 ASN A 289 GLU A 290 TYR A 291 CYS A 292 SITE 4 AC3 16 GLY A 295 PHE A 346 ASP A 380 LEU A 381 CRYST1 68.810 68.810 58.040 90.00 90.00 120.00 P 32 3 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014533 0.008390 0.000000 0.00000 SCALE2 0.000000 0.016781 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017229 0.00000